Docosapentaenoic (DPA) 22:5 n3

Optimal result: 0.34 – 5 wt %

Elevated DPA is seen with high intake of marine fish and other food sources, as well as with supplementation. High levels are less likely due to problems with downstream metabolism to DHA since it’s been shown to retro convert to EPA as a regulator and reservoir of the omega-3 fatty acids. DPA’s anti-inflammatory effects have been studied in many conditions such as inflammatory bowel disease, peripheral vascular disease, cardiovascular disease, cognitive decline, and stroke.

Docosapentaenoic acid (DPA) is an omega-3 fatty acid with 22 carbons and five double bonds (22:5n3). It is formed from its precursor, EPA, by way of the elongase enzyme which adds two carbons. It can be supplemented or obtained in the diet from foods such as marine oily fish.

Not only is DPA found in most fish and marine foods but it is also present in lean red meat from ruminant animals.

Docosapentaenoic acid (DPA) is an omega-3 fatty acid with 22 carbons and five double bonds (22:5n3). It is formed from its precursor, EPA, by way of the elongase enzyme which adds two carbons. It can be supplemented or obtained in the diet from foods such as marine oily fish.

Not only is DPA found in most fish and marine foods but it is also present in lean red meat from ruminant animals.

DPA is often overlooked and overshadowed by the significant amount of research on its precursor EPA and downstream metabolite docosahexaenoic acid (DHA). Both EPA and DHA are widely studied and commonly available as fish oil supplements. However, DPA is also found to have significant clinical importance. DPA inhibits cyclooxygenase-1 and is a potent inhibitor of platelet aggregation. It also has been shown to suppress lipogenesis to regulate lipolysis in favor of increased lipid oxidation for energy. It’s beneficial role in cardiovascular disease has also been studied. DPA can be retroconverted to EPA. Some research suggests that DPA can function as a reservoir or buffer of the other omega-3 fatty acids.

References:

- Miller E, Kaur G, Larsen A, et al. A short-term n-3 DPA supplementation study in humans. European journal of nutrition. 2013;52(3):895-904.

- Zheng Z, Dai Z, Cao Y, Shen Q, Zhang Y. Docosapentaenoic acid (DPA, 22: 5n-3) ameliorates inflammation in an ulcerative colitis model. Food & function. 2019;10(7):4199- 4209.

- Costea I, Mack DR, Lemaitre RN, et al. Interactions between the dietary polyunsaturated fatty acid ratio and genetic factors determine susceptibility to pediatric Crohn’s disease. Gastroenterology. 2014;146(4):929-931. e923.

- Leng G, Horrobin D, Fowkes F, et al. Plasma essential fatty acids, cigarette smoking, and dietary antioxidants in peripheral arterial disease. A population-based casecontrol study. Arteriosclerosis and thrombosis: a journal of vascular biology. 1994;14(3):471-478.

- Rissanen T, Voutilainen S, Nyyssönen K, Lakka TA, Salonen JT. Fish oil–derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events: the Kuopio ischaemic heart disease risk factor study. Circulation. 2000;102(22):2677-2679.

- Dyall SC. Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. Frontiers in aging neuroscience. 2015;7:52.

- Saber H, Yakoob MY, Shi P, et al. Omega-3 fatty acids and incident ischemic stroke and its atherothrombotic and cardioembolic subtypes in 3 US cohorts. Stroke. 2017;48(10):2678-2685.

Docosapentaenoic (DPA) 22:5 n3
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Docosapentaenoic (DPA) 22:5 n3 — 10,000+ markers explained
One Docosapentaenoic (DPA) 22:5 n3 result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro